《大行報告》里昂:對中國新能源汽車海外市場競爭力維持樂觀看法
里昂發表報告指,歐盟對中國進口電動車展開反補貼調查,可能採取的措施和時間表尚未明確。里昂指,考慮到在歐盟銷售的中國新能源汽車數量相對較少,且大部分在歐洲生產,預計今次調查短期影響有限。
里昂對內地新能源汽車在海外市場的競爭力保持樂觀,認為歐盟消費者最終會根據產品競爭力下訂單。未來將看到中國新能源汽車出現更廣泛的出口形式,如整車出口、技術出口、與當地整車廠深度合作、在海外建廠等,實現互利共贏。最於將有助於中國整車廠擴大海外佈局,創造增量收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.